A Covid-19 jab that works on all mutants and variants, such as Delta, Omicron, and the next worst mutation. As it turns out, the U.S. Army is planning to make our wishes come true.
The US Army, according to researchers, has developed a single weapon against all Covid-19 and SARS strains. Scientists at the Walter Reed Army Institute of Research will officially announce the creation of a vaccine in the coming weeks, according to Defense One.
The army-developed vaccine is effective against all coronavirus strains, including Omicron. Furthermore, it is effective against SARS-origin viruses, which are more deadly and have a greater fatality rate than Covid-19.
Animal trials of the vaccine known as SpFN were concluded earlier this year, and the findings were encouraging.
The first phase of human testing for SpFN concluded this month. Dr. Kayvon Modjarrad of Walter Reed indicated in an interview with Defense One that human vaccine studies yielded promising results.
SpFN harnesses the potential of a protein resembling a soccer ball with “24 faces.” Each face may be armed with different strains of Covid-19 and other related viruses, providing all-around defense against a number of dangers.
The vaccine must now go through two more steps of human testing before being made available to the public. SpFN has been under development for about two years, with some delays since researchers wanted individuals who had not been vaccinated or infected with Covid-19, which is difficult to locate today that countries are racing to vaccine everyone.
The regimen and dosage of the vaccine are currently unknown. It’s unclear if it’s a single-dose shot, as Johnson & Johnson, or a two-dose regimen, like Moderna, Pfizer, and AstraZeneca.
“We need to evaluate it in the real-world setting and try to understand how does the vaccine perform in much larger numbers of individuals who have already been vaccinated with something else initially…or already been sick,” said Dr. Kayvon Modjarrad, director of Walter Reed’s infectious diseases branch.
Regardless, with the risk of Omicron variant looming, governments are taking booster doses more seriously than ever before.
Image Credit: army.mil